| Year |
Citation |
Score |
| 2024 |
Bi C, Huang Y, Ali R, Wang F, Yang X, Bouska A, Xu L, Hao X, Lunning MA, Chan WC, Iqbal J, Weisenburger DD, Vose JM, Fu K. MYC overexpression in natural killer cell lymphoma: prognostic and therapeutic implications. Haematologica. PMID 38546691 DOI: 10.3324/haematol.2023.283811 |
0.392 |
|
| 2023 |
Wu G, Yoshida N, Liu J, Zhang X, Xiong Y, Heavican-Foral TB, Mandato E, Liu H, Nelson GM, Yang L, Chen R, Donovan KA, Jones MK, Roshal M, Zhang Y, ... ... Chan WC, et al. TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence. Science Translational Medicine. 15: eadi7244. PMID 37729434 DOI: 10.1126/scitranslmed.adi7244 |
0.338 |
|
| 2023 |
Song JY, Nwangwu M, He TF, Zhang W, Meawad H, Bedell V, Murata-Collins J, Skrabek P, Nasr MR, Scott D, Godfrey J, Lee P, Chan WC, Weisenburger DD, Perry AM, et al. Low T-cell proportion in the tumor microenvironment is associated with immune escape and poor survival in diffuse large B-cell lymphoma. Haematologica. PMID 36632739 DOI: 10.3324/haematol.2022.282265 |
0.411 |
|
| 2022 |
Feldman AL, Laurent C, Narbaitz M, Nakamura S, Chan WC, de Leval L, Gaulard P. Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas. Virchows Archiv : An International Journal of Pathology. PMID 36210383 DOI: 10.1007/s00428-022-03412-6 |
0.376 |
|
| 2022 |
King RL, Hsi ED, Chan WC, Piris MA, Cook JR, Scott DW, Swerdlow SH. Diagnostic approaches and future directions in Burkitt lymphoma and high-grade B-cell lymphoma. Virchows Archiv : An International Journal of Pathology. PMID 36057749 DOI: 10.1007/s00428-022-03404-6 |
0.355 |
|
| 2022 |
Amador C, Bouska A, Wright G, Weisenburger DD, Feldman AL, Greiner TC, Lone W, Heavican T, Smith L, Pileri S, Tabanelli V, Ott G, Rosenwald A, Savage KJ, Slack G, ... ... Chan WC, et al. Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2102707. PMID 35839444 DOI: 10.1200/JCO.21.02707 |
0.354 |
|
| 2022 |
Dong G, Liu X, Wang L, Yin W, Bouska A, Gong Q, Shetty K, Chen L, Sharma S, Zhang J, Lome-Maldonado C, Quintanilla-Martinez L, Li Y, Song JY, Zhang W, ... ... Chan WC, et al. Genomic profiling identifies distinct genetic subtypes in extra-nodal natural killer/T-cell lymphoma. Leukemia. PMID 35697790 DOI: 10.1038/s41375-022-01623-z |
0.329 |
|
| 2022 |
Zhang J, Wang T, Shetty K, Alkan S, Xu S, Gong Q, Liu X, Li Y, Hu Z, Huang W, Wendel HG, Herrera AF, Pillai RK, Song JY, Chan WC. Genetic characterization and drug sensitivity study of newly derived HGBL double/triple-hit lymphoma cell lines. Blood Advances. PMID 35687491 DOI: 10.1182/bloodadvances.2021006709 |
0.32 |
|
| 2022 |
Herek TA, Bouska A, Lone WG, Sharma S, Amador C, Heavican-Foral TB, Li Y, Wei Q, Jochum D, Greiner TC, Smith LM, Pileri SA, Feldman A, Rosenwald A, Ott G, ... ... Chan WC, et al. DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T-cells in PTCL-NOS. Blood. PMID 35639959 DOI: 10.1182/blood.2021015019 |
0.362 |
|
| 2021 |
Ramis-Zaldivar JE, Gonzalez-Farre B, Nicolae A, Pack S, Clot G, Nadeu F, Mottok A, Horn H, Song JY, Fu K, Wright G, Gascoyne RD, Chan WC, Scott DW, Feldman AL, et al. MAP-kinase and JAK-STAT pathways dysregulation in plasmablastic lymphoma. Haematologica. PMID 33951889 DOI: 10.3324/haematol.2020.271957 |
0.304 |
|
| 2021 |
Nguyen H, Perry A, Skrabek P, Nasr M, Herrera AF, Bedell V, Murata-Collins J, Pillai R, Xu M, Chen L, Chan WC, Weisenburger DD, Scott DW, Song JY. Validation of the double-hit gene expression signature (DLBCL90) in an independent cohort of patients with diffuse large B-cell lymphoma of germinal center origin. The Journal of Molecular Diagnostics : Jmd. PMID 33636392 DOI: 10.1016/j.jmoldx.2021.02.005 |
0.387 |
|
| 2020 |
Akman B, Hu X, Liu X, Hatipoğlu T, You H, Chan WC, Küçük C. PRDM1 decreases sensitivity of human NK cells to IL2-induced cell expansion by directly repressing CD25 (IL2RA). Journal of Leukocyte Biology. PMID 33145806 DOI: 10.1002/JLB.2A0520-321RR |
0.626 |
|
| 2020 |
Dong G, Li Y, Lee L, Liu X, Shi Y, Liu X, Bouska A, Gong Q, Kong L, Wang J, Lou CH, McKeithan TW, Iqbal J, Chan WC. Genetic manipulation of primary human natural killer cells to investigate the functional and oncogenic roles of PRDM1. Haematologica. PMID 32732362 DOI: 10.3324/Haematol.2020.254276 |
0.409 |
|
| 2020 |
Fragliasso V, Verma A, Manzotti G, Tameni A, Bareja R, Heavican TB, Iqbal J, Wang R, Fiore D, Mularoni V, Chan WC, Lhoumaud P, Skok J, Zanetti E, Merli F, et al. The novel lncRNA BlackMamba controls the neoplastic phenotype of ALK anaplastic large cell lymphoma by regulating the DNA helicase HELLS. Leukemia. PMID 32123306 DOI: 10.1038/S41375-020-0754-8 |
0.329 |
|
| 2020 |
Song JY, Egan C, Bouska AC, Zhang W, Gong Q, Venkataraman G, Herrera AF, Chen L, Ottesen R, Niland JC, Bedell V, Valle-Catuna M, Murata-Collins J, Weisenburger DD, Iqbal J, ... ... Chan WC, et al. Genomic characterization of diffuse large B-cell lymphoma transformation of nodular lymphocyte-predominant Hodgkin lymphoma. Leukemia. PMID 32054999 DOI: 10.1038/s41375-020-0739-7 |
0.31 |
|
| 2019 |
Heavican TB, Bouska A, Yu J, Lone W, Amador C, Gong Q, Zhang W, Li Y, Dave BJ, Nairismägi ML, Greiner TC, Vose J, Weisenburger DD, Lachel C, Wang C, ... ... Chan WC, et al. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood. PMID 30782609 DOI: 10.1182/Blood-2018-09-872549 |
0.321 |
|
| 2019 |
Iqbal J, Amador C, McKeithan TW, Chan WC. Molecular and Genomic Landscape of Peripheral T-Cell Lymphoma. Cancer Treatment and Research. 176: 31-68. PMID 30596212 DOI: 10.1007/978-3-319-99716-2_2 |
0.306 |
|
| 2018 |
Mohanty A, Sandoval N, Phan A, Nguyen TV, Chen RW, Budde E, Mei M, Popplewell L, Pham LV, Kwak LW, Weisenburger DD, Rosen ST, Chan WC, Müschen M, Ngo VN. Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma. Blood. PMID 30530749 DOI: 10.1182/Blood-2018-05-851667 |
0.307 |
|
| 2018 |
Mottok A, Wright G, Rosenwald A, Ott G, Ramsower C, Campo E, Braziel RM, Delabie J, Weisenburger DD, Song JY, Chan WC, Cook JR, Fu K, Greiner T, Smeland E, et al. Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens. Blood. PMID 30257882 DOI: 10.1182/Blood-2018-05-851154 |
0.33 |
|
| 2018 |
Phelan JD, Young RM, Webster DE, Roulland S, Wright GW, Kasbekar M, Shaffer AL, Ceribelli M, Wang JQ, Schmitz R, Nakagawa M, Bachy E, Huang DW, Ji Y, Chen L, ... ... Chan WC, et al. A multiprotein supercomplex controlling oncogenic signalling in lymphoma. Nature. PMID 29925955 DOI: 10.1038/S41586-018-0290-0 |
0.349 |
|
| 2018 |
Zhang XH, Nam S, Wu J, Chen CH, Liu X, Li H, McKeithan T, Gong Q, Chan WC, Yin HH, Yuan YC, Pillai R, Querfeld C, Horne D, Chen Y, et al. Multi-kinase inhibitor with anti-p38γ activity in cutaneous T cell lymphoma. The Journal of Investigative Dermatology. PMID 29758280 DOI: 10.1016/j.jid.2018.04.030 |
0.346 |
|
| 2018 |
Dufva O, Kankainen M, Kelkka T, Sekiguchi N, Awad SA, Eldfors S, Yadav B, Kuusanmäki H, Malani D, Andersson EI, Pietarinen P, Saikko L, Kovanen PE, Ojala T, Lee DA, ... ... Chan WC, et al. Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target. Nature Communications. 9: 1567. PMID 29674644 DOI: 10.1038/s41467-018-03987-2 |
0.347 |
|
| 2018 |
Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, Roulland S, Kasbekar M, Young RM, Shaffer AL, Hodson DJ, Xiao W, Yu X, Yang Y, Zhao H, ... ... Chan WC, et al. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma. The New England Journal of Medicine. 378: 1396-1407. PMID 29641966 DOI: 10.1056/Nejmoa1801445 |
0.366 |
|
| 2017 |
El Behery R, Laurini JA, Weisenburger DD, Smith LM, Dave BJ, Yuan J, Fu K, Chan WC, Nathwani BN, Bierman PJ, Bociek RG, Vose JM, Armitage JO, Greiner TC, Aoun P. Follicular large cleaved cell (centrocytic) lymphoma: An unrecognized variant of follicular lymphoma. Human Pathology. PMID 29170017 DOI: 10.1016/j.humpath.2017.11.002 |
0.367 |
|
| 2017 |
Gong Q, Wang C, Zhang W, Iqbal J, Hu Y, Greiner TC, Cornish A, Kim JH, Rabadan R, Abate F, Wang X, Inghirami GG, McKeithan TW, Chan WC. Assessment of T-cell receptor repertoire and clonal expansion in peripheral T-cell lymphoma using RNA-seq data. Scientific Reports. 7: 11301. PMID 28900149 DOI: 10.1038/S41598-017-11310-0 |
0.38 |
|
| 2017 |
Bouska A, Bi C, Lone W, Zhang W, Kedwaii A, Heavican T, Lachel CM, Yu J, Ferro R, Eldorghamy N, Greiner TC, Vose J, Weisenburger DD, Gascoyne RD, Rosenwald A, ... ... Chan WC, et al. Adult High Grade B-cell Lymphoma with Burkitt Lymphoma Signature: Genomic features and Potential Therapeutic Targets. Blood. PMID 28801451 DOI: 10.1182/Blood-2017-02-767335 |
0.318 |
|
| 2017 |
Herrmann A, Lahtz C, Nagao T, Song JY, Chan WC, Lee H, Yue C, Look T, Muelfarth R, Li W, Jenkins K, Williams J, Budde LE, Forman SJ, Kwak LW, et al. CTLA4 promotes Tyk2-STAT3 dependent B cell oncogenecity. Cancer Research. PMID 28716895 DOI: 10.1158/0008-5472.Can-16-0342 |
0.423 |
|
| 2017 |
Baytak E, Gong Q, Akman B, Yuan H, Chan WC, Küçük C. Whole transcriptome analysis reveals dysregulated oncogenic lncRNAs in natural killer/T-cell lymphoma and establishes MIR155HG as a target of PRDM1. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 39: 1010428317701648. PMID 28468592 DOI: 10.1177/1010428317701648 |
0.656 |
|
| 2017 |
McKinney M, Moffitt AB, Gaulard P, Travert M, De Leval L, Nicolae A, Raffeld M, Jaffe ES, Pittaluga S, Xi L, Heavican T, Iqbal J, Belhadj K, Delfau-Larue MH, Fataccioli V, ... ... Chan WC, et al. The Genetic Basis of Hepatosplenic T Cell Lymphoma. Cancer Discovery. PMID 28122867 DOI: 10.1158/2159-8290.Cd-16-0330 |
0.304 |
|
| 2016 |
Boice M, Salloum D, Mourcin F, Sanghvi V, Amin R, Oricchio E, Jiang M, Mottok A, Denis-Lagache N, Ciriello G, Tam W, Teruya-Feldstein J, de Stanchina E, Chan WC, Malek SN, et al. Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells. Cell. PMID 27693350 DOI: 10.1016/j.cell.2016.08.032 |
0.435 |
|
| 2016 |
Küçük C, Hu X, Gong Q, Jiang B, Cornish A, Gaulard P, McKeithan T, Chan WC. Diagnostic and Biological Significance of KIR Expression Profile Determined by RNA-Seq in Natural Killer/T-Cell Lymphoma. The American Journal of Pathology. PMID 27060228 DOI: 10.1016/J.Ajpath.2016.02.011 |
0.672 |
|
| 2016 |
Gao LM, Zhao S, Liu WP, Zhang WY, Li GD, Küçük C, Hu XZ, Chan WC, Tang Y, Ding WS, Yan JQ, Yao WQ, Wang JC. Clinicopathologic Characterization of Aggressive Natural Killer Cell Leukemia Involving Different Tissue Sites. The American Journal of Surgical Pathology. PMID 26975038 DOI: 10.1097/Pas.0000000000000634 |
0.619 |
|
| 2015 |
Kendrick S, Tus K, Wright G, Jaffe ES, Rosenwald A, Campo E, Chan WC, Connors JM, Braziel RM, Ott G, Delabie J, Cook JR, Weisenburger DD, Greiner TC, Fu K, et al. Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status. Leukemia & Lymphoma. 1-4. PMID 26437080 DOI: 10.3109/10428194.2015.1072767 |
0.38 |
|
| 2015 |
Iqbal J, Naushad H, Bi C, Yu J, Bouska A, Rohr J, Chao W, Fu K, Chan WC, Vose JM. Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis? Blood Reviews. PMID 26432520 DOI: 10.1016/J.Blre.2015.08.002 |
0.313 |
|
| 2015 |
Takahashi K, Sivina M, Hoellenriegel J, Oki Y, Hagemeister FB, Fayad L, Romaguera JE, Fowler N, Fanale MA, Kwak LW, Samaniego F, Neelapu S, Xiao L, Huang X, Kantarjian H, ... ... Chan WC, et al. CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma. British Journal of Haematology. PMID 26358140 DOI: 10.1111/bjh.13659 |
0.338 |
|
| 2015 |
Iqbal J, Wilcox R, Naushad H, Rohr J, Heavican TB, Wang C, Bouska A, Fu K, Chan WC, Vose JM. Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis? Blood Reviews. PMID 26319391 DOI: 10.1016/j.blre.2015.08.003 |
0.349 |
|
| 2015 |
Wang C, McKeithan TW, Gong Q, Zhang W, Bouska A, Rosenwald A, Gascoyne RD, Wu X, Wang J, Muhammad Z, Jiang B, Rohr J, Cannon A, Steidl C, Fu K, ... ... Chan WC, et al. IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma. Blood. PMID 26268241 DOI: 10.1182/Blood-2015-05-644591 |
0.346 |
|
| 2015 |
Yuan J, Wright G, Rosenwald A, Steidl C, Gascoyne RD, Connors JM, Mottok A, Weisenburger DD, Greiner TC, Fu K, Smith L, Rimsza LM, Jaffe ES, Campo E, Martinez A, ... ... Chan WC, et al. Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling. The American Journal of Surgical Pathology. PMID 26135560 DOI: 10.1097/Pas.0000000000000473 |
0.303 |
|
| 2015 |
Crescenzo R, Abate F, Lasorsa E, Tabbo' F, Gaudiano M, Chiesa N, Di Giacomo F, Spaccarotella E, Barbarossa L, Ercole E, Todaro M, Boi M, Acquaviva A, Ficarra E, Novero D, ... ... Chan WC, et al. Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer Cell. 27: 516-32. PMID 25873174 DOI: 10.1016/j.ccell.2015.03.006 |
0.335 |
|
| 2015 |
Küçük C, Hu X, McKeithan T, Chan WC. Lack of evidence that HACE1 is not a tumor suppressor gene in NKTCL: to the editor-in-chief. The American Journal of Pathology. 185: 1167-8. PMID 25794710 DOI: 10.1016/J.Ajpath.2014.10.028 |
0.581 |
|
| 2015 |
Küçük C, Hu X, Jiang B, Klinkebiel D, Geng H, Gong Q, Bouska A, Iqbal J, Gaulard P, McKeithan TW, Chan WC. Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1699-711. PMID 25614448 DOI: 10.1158/1078-0432.Ccr-14-1216 |
0.65 |
|
| 2015 |
Küçük C, Jiang B, Hu X, Zhang W, Chan JK, Xiao W, Lack N, Alkan C, Williams JC, Avery KN, Kavak P, Scuto A, Sen E, Gaulard P, Staudt L, ... ... Chan WC, et al. Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells. Nature Communications. 6: 6025. PMID 25586472 DOI: 10.1038/Ncomms7025 |
0.649 |
|
| 2015 |
Inghirami G, Chan WC, Pileri S. Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications. Immunological Reviews. 263: 124-59. PMID 25510275 DOI: 10.1111/imr.12248 |
0.361 |
|
| 2015 |
Iqbal J, Shen Y, Huang X, Liu Y, Wake L, Liu C, Deffenbacher K, Lachel CM, Wang C, Rohr J, Guo S, Smith LM, Wright G, Bhagavathi S, Dybkaer K, ... ... Chan WC, et al. Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma. Blood. 125: 1137-45. PMID 25498913 DOI: 10.1182/Blood-2014-04-566778 |
0.325 |
|
| 2014 |
Muppidi JR, Schmitz R, Green JA, Xiao W, Larsen AB, Braun SE, An J, Xu Y, Rosenwald A, Ott G, Gascoyne RD, Rimsza LM, Campo E, Jaffe ES, Delabie J, ... ... Chan WC, et al. Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma. Nature. 516: 254-8. PMID 25274307 DOI: 10.1038/Nature13765 |
0.325 |
|
| 2014 |
Kendrick SL, Redd L, Muranyi A, Henricksen LA, Stanislaw S, Smith LM, Perry AM, Fu K, Weisenburger DD, Rosenwald A, Ott G, Gascoyne RD, Jaffe ES, Campo E, Delabie J, ... ... Chan WC, et al. BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma. Human Pathology. 45: 2144-53. PMID 25090918 DOI: 10.1016/J.Humpath.2014.06.005 |
0.327 |
|
| 2014 |
Green MR, Vicente-Dueñas C, Romero-Camarero I, Long Liu C, Dai B, González-Herrero I, García-Ramírez I, Alonso-Escudero E, Iqbal J, Chan WC, Campos-Sanchez E, Orfao A, Pintado B, Flores T, Blanco O, et al. Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma. Nature Communications. 5: 3904. PMID 24887457 DOI: 10.1038/Ncomms4904 |
0.428 |
|
| 2014 |
Iqbal J, Wright G, Wang C, Rosenwald A, Gascoyne RD, Weisenburger DD, Greiner TC, Smith L, Guo S, Wilcox RA, Teh BT, Lim ST, Tan SY, Rimsza LM, Jaffe ES, ... ... Chan WC, et al. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood. 123: 2915-23. PMID 24632715 DOI: 10.1182/Blood-2013-11-536359 |
0.455 |
|
| 2014 |
Perry AM, Alvarado-Bernal Y, Laurini JA, Smith LM, Slack GW, Tan KL, Sehn LH, Fu K, Aoun P, Greiner TC, Chan WC, Bierman PJ, Bociek RG, Armitage JO, Vose JM, et al. MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab. British Journal of Haematology. 165: 382-91. PMID 24506200 DOI: 10.1111/bjh.12763 |
0.301 |
|
| 2014 |
Scott DW, Wright GW, Williams PM, Lih CJ, Walsh W, Jaffe ES, Rosenwald A, Campo E, Chan WC, Connors JM, Smeland EB, Mottok A, Braziel RM, Ott G, Delabie J, et al. Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue. Blood. 123: 1214-7. PMID 24398326 DOI: 10.1182/Blood-2013-11-536433 |
0.383 |
|
| 2014 |
Spaccarotella E, Pellegrino E, Ferracin M, Ferreri C, Cuccuru G, Liu C, Iqbal J, Cantarella D, Taulli R, Provero P, Di Cunto F, Medico E, Negrini M, Chan WC, Inghirami G, et al. STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma. Haematologica. 99: 116-24. PMID 23975180 DOI: 10.3324/Haematol.2013.088286 |
0.368 |
|
| 2013 |
Huang X, Meng B, Iqbal J, Ding BB, Perry AM, Cao W, Smith LM, Bi C, Jiang C, Greiner TC, Weisenburger DD, Rimsza L, Rosenwald A, Ott G, Delabie J, ... ... Chan WC, et al. Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 4520-8. PMID 24220563 DOI: 10.1200/Jco.2012.45.6004 |
0.326 |
|
| 2013 |
Perry AM, Warnke RA, Hu Q, Gaulard P, Copie-Bergman C, Alkan S, Wang HY, Cheng JX, Bacon CM, Delabie J, Ranheim E, Kucuk C, Hu X, Weisenburger DD, Jaffe ES, ... Chan WC, et al. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. Blood. 122: 3599-606. PMID 24009234 DOI: 10.1182/Blood-2013-07-512830 |
0.633 |
|
| 2013 |
Liu C, Iqbal J, Teruya-Feldstein J, Shen Y, Dabrowska MJ, Dybkaer K, Lim MS, Piva R, Barreca A, Pellegrino E, Spaccarotella E, Lachel CM, Kucuk C, Jiang CS, Hu X, ... ... Chan WC, et al. MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. Blood. 122: 2083-92. PMID 23801630 DOI: 10.1182/Blood-2012-08-447375 |
0.551 |
|
| 2013 |
Pan Z, Xie Q, Repertinger S, Richendollar BG, Chan WC, Huang Q. Plasmablastic transformation of low-grade CD5+ B-cell lymphoproliferative disorder with MYC gene rearrangements Human Pathology. 44: 2139-2148. PMID 23791008 DOI: 10.1016/J.Humpath.2013.04.008 |
0.636 |
|
| 2013 |
Mitrovic Z, Iqbal J, Fu K, Smith LM, Bast M, Greiner TC, Aoun P, Armitage JO, Vose JM, Weisenburger DD, Chan WC. CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell lymphoma British Journal of Haematology. 162: 87-92. PMID 23617469 DOI: 10.1111/bjh.12356 |
0.317 |
|
| 2013 |
Perry AM, Crockett D, Dave BJ, Althof P, Winkler L, Smith LM, Aoun P, Chan WC, Fu K, Greiner TC, Bierman P, Gregory Bociek R, Vose JM, Armitage JO, Weisenburger DD. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases. British Journal of Haematology. 162: 40-9. PMID 23600716 DOI: 10.1111/Bjh.12343 |
0.35 |
|
| 2013 |
Küçük C, Hu X, Iqbal J, Gaulard P, Klinkebiel D, Cornish A, Dave BJ, Chan WC. HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms. The American Journal of Pathology. 182: 49-55. PMID 23142381 DOI: 10.1016/J.Ajpath.2012.09.012 |
0.67 |
|
| 2012 |
Bertino JR, Lubin M, Johnson-Farley N, Chan WC, Goodell L, Bhagavathi S. Lack of expression of MTAP in uncommon T-Cell lymphomas Clinical Lymphoma, Myeloma and Leukemia. 12: 306-309. PMID 23040436 DOI: 10.1016/J.Clml.2012.07.001 |
0.361 |
|
| 2012 |
Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, ... ... Chan WC, et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 490: 116-20. PMID 22885699 DOI: 10.1038/Nature11378 |
0.382 |
|
| 2012 |
Johnson NA, Slack GW, Savage KJ, Connors JM, Ben-Neriah S, Rogic S, Scott DW, Tan KL, Steidl C, Sehn LH, Chan WC, Iqbal J, Meyer PN, Lenz G, Wright G, et al. Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 3452-9. PMID 22851565 DOI: 10.1200/Jco.2011.41.0985 |
0.324 |
|
| 2012 |
Agnelli L, Mereu E, Pellegrino E, Limongi T, Kwee I, Bergaggio E, Ponzoni M, Zamò A, Iqbal J, Piccaluga PP, Neri A, Chan WC, Pileri S, Bertoni F, Inghirami G, et al. Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma. Blood. 120: 1274-81. PMID 22740451 DOI: 10.1182/blood-2012-01-405555 |
0.355 |
|
| 2012 |
Deffenbacher KE, Iqbal J, Sanger W, Shen Y, Lachel C, Liu Z, Liu Y, Lim MS, Perkins SL, Fu K, Smith L, Lynch J, Staudt LM, Rimsza LM, Jaffe E, ... ... Chan WC, et al. Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling. Blood. 119: 3757-66. PMID 22374697 DOI: 10.1182/Blood-2011-05-349662 |
0.346 |
|
| 2012 |
Gu K, Weisenburger DD, Fu K, Chan WC, Greiner TC, Aoun P, Smith LM, Bast M, Liu Z, Bociek RG, Bierman PJ, Armitage JO, Vose JM. Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation Hematological Oncology. 30: 143-149. PMID 22009820 DOI: 10.1002/hon.1017 |
0.306 |
|
| 2011 |
Küçük C, Iqbal J, Hu X, Gaulard P, De Leval L, Srivastava G, Au WY, McKeithan TW, Chan WC. PRDM1 is a tumor suppressor gene in natural killer cell malignancies. Proceedings of the National Academy of Sciences of the United States of America. 108: 20119-24. PMID 22143801 DOI: 10.1073/Pnas.1115128108 |
0.426 |
|
| 2011 |
Iqbal J, Meyer PN, Smith LM, Johnson NA, Vose JM, Greiner TC, Connors JM, Staudt LM, Rimsza L, Jaffe E, Rosenwald A, Ott G, Delabie J, Campo E, Braziel RM, ... ... Chan WC, et al. BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 7785-95. PMID 21933893 DOI: 10.1158/1078-0432.Ccr-11-0267 |
0.348 |
|
| 2011 |
Cardesa-Salzmann TM, Colomo L, Gutierrez G, Chan WC, Weisenburger D, Climent F, González-Barca E, Mercadal S, Arenillas L, Serrano S, Tubbs R, Delabie J, Gascoyne RD, Connors JM, Mate JL, et al. High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy. Haematologica. 96: 996-1001. PMID 21546504 DOI: 10.3324/Haematol.2010.037408 |
0.347 |
|
| 2011 |
Rimsza LM, Wright G, Schwartz M, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, Cook JR, Tubbs RR, Braziel RM, Delabie J, Miller TP, Staudt LM. Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues Clinical Cancer Research. 17: 3727-3732. PMID 21364035 DOI: 10.1158/1078-0432.Ccr-10-2573 |
0.336 |
|
| 2011 |
Visco C, Hoeller S, Malik JT, Xu-Monette ZY, Wiggins ML, Liu J, Sanger WG, Liu Z, Chang J, Ranheim EA, Gradowski JF, Serrano S, Wang HY, Liu Q, Dave S, ... ... Chan WC, et al. Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell component. The American Journal of Surgical Pathology. 35: 177-89. PMID 21263238 DOI: 10.1097/PAS.0b013e3182049a9c |
0.343 |
|
| 2011 |
Meyer PN, Fu K, Greiner T, Smith L, Delabie J, Gascoyne R, Ott G, Rosenwald A, Braziel R, Campo E, Vose J, Lenz G, Staudt L, Chan W, Weisenburger DD. The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximab. American Journal of Clinical Pathology. 135: 54-61. PMID 21173124 DOI: 10.1309/Ajcpjx4Bjv9Nlqhy |
0.379 |
|
| 2011 |
Meyer PN, Fu K, Greiner TC, Smith LM, Delabie J, Gascoyne RD, Ott G, Rosenwald A, Braziel RM, Campo E, Vose JM, Lenz G, Staudt LM, Chan WC, Weisenburger DD. Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 200-7. PMID 21135273 DOI: 10.1200/Jco.2010.30.0368 |
0.33 |
|
| 2010 |
Fox CP, Haigh TA, Taylor GS, Long HM, Lee SP, Shannon-Lowe C, O'Connor S, Bollard CM, Iqbal J, Chan WC, Rickinson AB, Bell AI, Rowe M. A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy. Blood. 116: 3695-704. PMID 20671118 DOI: 10.1182/blood-2010-06-292268 |
0.353 |
|
| 2010 |
Chan WC. Pathogenesis of diffuse large B cell lymphoma International Journal of Hematology. 92: 219-230. PMID 20582737 DOI: 10.1007/s12185-010-0602-0 |
0.339 |
|
| 2010 |
Deffenbacher KE, Iqbal J, Liu Z, Fu K, Chan WC. Recurrent chromosomal alterations in molecularly classified AIDS-related lymphomas: An integrated analysis of DNA copy number and gene expression Journal of Acquired Immune Deficiency Syndromes. 54: 18-26. PMID 20216076 DOI: 10.1097/QAI.0b013e3181d3d9eb |
0.381 |
|
| 2010 |
Chan WC, Armitage JO. Genomic analysis of lymphoma: Potential for clinical application Jnccn Journal of the National Comprehensive Cancer Network. 8: 353-360. PMID 20202465 DOI: 10.6004/JNCCN.2010.0024 |
0.39 |
|
| 2010 |
Tierens AM, Holte H, Warsame A, Ikonomou IM, Wang J, Chan WC, Delabie J. Low levels of monoclonal small B cells in the bone marrow of patients with diffuse large B-cell lymphoma of activated B-cell type but not of germinal center B-cell type Haematologica. 95: 1334-1341. PMID 20145271 DOI: 10.3324/Haematol.2009.014100 |
0.345 |
|
| 2010 |
Chen Y, Han T, Iqbal J, Irons R, Chan WC, Zhu X, Fu K. Diffuse large B-cell lymphoma in Chinese patients American Journal of Clinical Pathology. 133: 305-313. PMID 20093241 DOI: 10.1309/AJCP4H6ADGYDZMOA |
0.307 |
|
| 2010 |
Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, Xu W, Shaffer AL, Wright G, Xiao W, Powell J, ... ... Chan WC, et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature. 463: 88-92. PMID 20054396 DOI: 10.1038/Nature08638 |
0.346 |
|
| 2010 |
Iqbal J, Weisenburger DD, Greiner TC, Vose JM, McKeithan T, Kucuk C, Geng H, Deffenbacher K, Smith L, Dybkaer K, Nakamura S, Seto M, Delabie J, Berger F, Loong F, ... ... Chan WC, et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood. 115: 1026-36. PMID 19965671 DOI: 10.1182/Blood-2009-06-227579 |
0.687 |
|
| 2009 |
Hailfinger S, Lenz G, Ngo V, Posvitz-Fejfar A, Rebeaud F, Guzzardi M, Penas EM, Dierlamm J, Chan WC, Staudt LM, Thome M. Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 106: 19946-51. PMID 19897720 DOI: 10.1073/Pnas.0907511106 |
0.326 |
|
| 2009 |
Choi WW, Weisenburger DD, Greiner TC, Piris MA, Banham AH, Delabie J, Braziel RM, Geng H, Iqbal J, Lenz G, Vose JM, Hans CP, Fu K, Smith LM, Li M, ... ... Chan WC, et al. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 5494-502. PMID 19706817 DOI: 10.1158/1078-0432.Ccr-09-0113 |
0.327 |
|
| 2009 |
Gu K, Fu K, Jain S, Liu Z, Iqbal J, Li M, Sanger WG, Weisenburger DD, Greiner TC, Aoun P, Dave BJ, Chan WC. t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 22: 1251-7. PMID 19465899 DOI: 10.1038/Modpathol.2009.81 |
0.334 |
|
| 2009 |
Rimsza LM, Chan WC, Gascoyne RD, Campo E, Jaffe ES, Staudt LM, Delabie J, Rosenwald A, Murphy SP. CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression. Haematologica. 94: 596-8. PMID 19229048 DOI: 10.3324/Haematol.2008.000752 |
0.349 |
|
| 2008 |
Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, Davis RE, Carty S, Lam LT, Shaffer AL, Xiao W, Powell J, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, ... ... Chan WC, et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proceedings of the National Academy of Sciences of the United States of America. 105: 13520-5. PMID 18765795 DOI: 10.1073/Pnas.0804295105 |
0.442 |
|
| 2008 |
Salaverria I, Zettl A, Beà S, Hartmann EM, Dave SS, Wright GW, Boerma EJ, Kluin PM, Ott G, Chan WC, Weisenburger DD, Lopez-Guillermo A, Gascoyne RD, Delabie J, Rimsza LM, et al. Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma. Haematologica. 93: 1327-34. PMID 18698080 DOI: 10.3324/Haematol.13071 |
0.334 |
|
| 2008 |
Fu K, Weisenburger DD, Choi WW, Perry KD, Smith LM, Shi X, Hans CP, Greiner TC, Bierman PJ, Bociek RG, Armitage JO, Chan WC, Vose JM. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 4587-94. PMID 18662967 DOI: 10.1200/JCO.2007.15.9277 |
0.382 |
|
| 2008 |
Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW, Dave SS, Zhao H, Xu W, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Rimsza LM, ... ... Chan WC, et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science (New York, N.Y.). 319: 1676-9. PMID 18323416 DOI: 10.1126/Science.1153629 |
0.347 |
|
| 2008 |
Young KH, Xie Q, Zhou G, Eickhoff JC, Sanger WG, Aoun P, Chan WC. Transformation of follicular lymphoma to precursor B-cell lymphoblastic lymphoma with c-myc gene rearrangement as a critical event. American Journal of Clinical Pathology. 129: 157-66. PMID 18089500 DOI: 10.1309/Nkk3Fex2Be5L7Ekb |
0.382 |
|
| 2008 |
Montes-Moreno S, Roncador G, Maestre L, Martínez N, Sanchez-Verde L, Camacho FI, Cannata J, Martinez-Torrecuadrada JL, Shen Y, Chan WC, Piris MA. Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas. Blood. 111: 351-8. PMID 17898315 DOI: 10.1182/blood-2007-06-094151 |
0.446 |
|
| 2007 |
Pan Z, Shen Y, Ge B, Du C, McKeithan T, Chan WC. Studies of a germinal centre B-cell expressed gene, GCET2, suggest its role as a membrane associated adapter protein. British Journal of Haematology. 137: 578-90. PMID 17489982 DOI: 10.1111/J.1365-2141.2007.06597.X |
0.662 |
|
| 2007 |
Lenz G, Nagel I, Siebert R, Roschke AV, Sanger W, Wright GW, Dave SS, Tan B, Zhao H, Rosenwald A, Muller-Hermelink HK, Gascoyne RD, Campo E, Jaffe ES, Smeland EB, ... ... Chan WC, et al. Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma. The Journal of Experimental Medicine. 204: 633-43. PMID 17353367 DOI: 10.1182/Blood.V108.11.356.356 |
0.351 |
|
| 2007 |
Davies AJ, Rosenwald A, Wright G, Lee A, Last KW, Weisenburger DD, Chan WC, Delabie J, Braziel RM, Campo E, Gascoyne RD, Jaffe ES, Muller-Hermelink K, Ott G, Calaminici M, et al. Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. British Journal of Haematology. 136: 286-93. PMID 17278262 DOI: 10.1111/j.1365-2141.2006.06439.x |
0.387 |
|
| 2006 |
Young KH, Chan WC, Fu K, Iqbal J, Sanger WG, Ratashak A, Greiner TC, Weisenburger DD. Mantle cell lymphoma with plasma cell differentiation. The American Journal of Surgical Pathology. 30: 954-61. PMID 16861965 DOI: 10.1097/00000478-200608000-00004 |
0.39 |
|
| 2006 |
Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, Müller-Hermelink HK, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, ... ... Chan WC, et al. Molecular diagnosis of Burkitt's lymphoma. The New England Journal of Medicine. 354: 2431-42. PMID 16760443 DOI: 10.1056/Nejmoa055759 |
0.333 |
|
| 2006 |
Tam W, Gomez M, Chadburn A, Lee JW, Chan WC, Knowles DM. Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas. Blood. 107: 4090-100. PMID 16424392 DOI: 10.1182/BLOOD-2005-09-3778 |
0.328 |
|
| 2006 |
Iqbal J, Neppalli VT, Wright G, Dave BJ, Horsman DE, Rosenwald A, Lynch J, Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Campo E, Ott G, Müller-Hermelink HK, Delabie J, ... ... Chan WC, et al. BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 961-8. PMID 16418494 DOI: 10.1200/Jco.2005.03.4264 |
0.376 |
|
| 2006 |
Rimsza LM, Roberts RA, Campo E, Grogan TM, Bea S, Salaverria I, Zettl A, Rosenwald A, Ott G, Muller-Hermelink HK, Delabie J, Fisher RI, Unger JM, Leblanc M, Staudt LM, ... ... Chan WC, et al. Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions. Blood. 107: 1101-7. PMID 16239429 DOI: 10.1182/Blood-2005-04-1510 |
0.325 |
|
| 2005 |
Bea S, Zettl A, Wright G, Salaverria I, Jehn P, Moreno V, Burek C, Ott G, Puig X, Yang L, Lopez-Guillermo A, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, et al. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood. 106: 3183-90. PMID 16046532 DOI: 10.1182/Blood-2005-04-1399 |
0.362 |
|
| 2005 |
Hans CP, Weisenburger DD, Greiner TC, Chan WC, Aoun P, Cochran GT, Pan Z, Smith LM, Lynch JC, Bociek RG, Bierman PJ, Vose JM, Armitage JO. Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 18: 1377-84. PMID 15920548 DOI: 10.1038/Modpathol.3800434 |
0.625 |
|
| 2005 |
Kaleem Z, McGuire MH, Caracioni AC, Leonard RL, Pathan MH, Lessmann EA, Chan WC. Composite B-cell and T-cell non-Hodgkin lymphoma of the tibia. American Journal of Clinical Pathology. 123: 215-21. PMID 15842045 |
0.304 |
|
| 2004 |
Dybkaer K, Zhou G, Iqbal J, Kelly D, Xiao L, Sherman S, d'Amore F, Chan WC. Suitability of stratagene reference RNA for analysis of lymphoid tissues. Biotechniques. 37: 470-2, 474. PMID 15470902 DOI: 10.2144/04373Rt03 |
0.341 |
|
| 2004 |
Shen Y, Iqbal J, Xiao L, Lynch RC, Rosenwald A, Staudt LM, Sherman S, Dybkaer K, Zhou G, Eudy JD, Delabie J, McKeithan TW, Chan WC. Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs. Bmc Immunology. 5: 20. PMID 15369600 DOI: 10.1186/1471-2172-5-20 |
0.352 |
|
| 2004 |
Dybkaer K, Iqbal J, Zhou G, Chan WC. Molecular diagnosis and outcome prediction in diffuse large B-cell lymphoma and other subtypes of lymphoma. Clinical Lymphoma. 5: 19-28. PMID 15245604 DOI: 10.3816/CLM.2004.N.006 |
0.378 |
|
| 2004 |
Shen Y, Iqbal J, Huang JZ, Zhou G, Chan WC. BCL2 protein expression parallels its mRNA level in normal and malignant B cells. Blood. 104: 2936-9. PMID 15242877 DOI: 10.1182/BLOOD-2004-01-0243 |
0.377 |
|
| 2004 |
Iqbal J, Sanger WG, Horsman DE, Rosenwald A, Pickering DL, Dave B, Dave S, Xiao L, Cao K, Zhu Q, Sherman S, Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, ... ... Chan WC, et al. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. The American Journal of Pathology. 165: 159-66. PMID 15215171 DOI: 10.1016/S0002-9440(10)63284-1 |
0.423 |
|
| 2004 |
Rimsza LM, Roberts RA, Miller TP, Unger JM, LeBlanc M, Braziel RM, Weisenberger DD, Chan WC, Muller-Hermelink HK, Jaffe ES, Gascoyne RD, Campo E, Fuchs DA, Spier CM, Fisher RI, et al. Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project. Blood. 103: 4251-8. PMID 14976040 DOI: 10.1182/Blood-2003-07-2365 |
0.325 |
|
| 2004 |
Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Müller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, ... ... Chan WC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 103: 275-82. PMID 14504078 DOI: 10.1182/Blood-2003-05-1545 |
0.67 |
|
| 2003 |
Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, Chan WC, Zhao T, Haioun C, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. The Journal of Experimental Medicine. 198: 851-62. PMID 12975453 DOI: 10.1084/Jem.20031074 |
0.428 |
|
| 2003 |
Pan Z, Shen Y, Du C, Zhou G, Rosenwald A, Staudt LM, Greiner TC, McKeithan TW, Chan WC. Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells. The American Journal of Pathology. 163: 135-44. PMID 12819018 DOI: 10.1016/S0002-9440(10)63637-1 |
0.69 |
|
| 2003 |
Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E, Gascoyne RD, Grogan TM, Muller-Hermelink HK, Smeland EB, Chiorazzi M, Giltnane JM, Hurt EM, Zhao H, Averett L, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell. 3: 185-97. PMID 12620412 DOI: 10.1016/S1535-6108(03)00028-X |
0.39 |
|
| 2002 |
Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. The New England Journal of Medicine. 346: 1937-47. PMID 12075054 DOI: 10.1056/Nejmoa012914 |
0.403 |
|
| 2002 |
Huang JZ, Sanger WG, Greiner TC, Staudt LM, Weisenburger DD, Pickering DL, Lynch JC, Armitage JO, Warnke RA, Alizadeh AA, Lossos IS, Levy R, Chan WC. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood. 99: 2285-90. PMID 11895757 DOI: 10.1182/Blood.V99.7.2285 |
0.417 |
|
| 2000 |
Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J, ... ... Chan WC, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 403: 503-11. PMID 10676951 DOI: 10.1038/35000501 |
0.395 |
|
| Show low-probability matches. |